216 related articles for article (PubMed ID: 34221955)
1. M6A "Writer" Gene
Cai C; Long J; Huang Q; Han Y; Peng Y; Guo C; Liu S; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
Front Oncol; 2021; 11():615296. PubMed ID: 34221955
[TBL] [Abstract][Full Text] [Related]
2. Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
Gong PJ; Shao YC; Yang Y; Song WJ; He X; Zeng YF; Huang SR; Wei L; Zhang JW
Front Oncol; 2020; 10():578963. PubMed ID: 33363011
[TBL] [Abstract][Full Text] [Related]
3. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
4. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
Front Genet; 2021; 12():790888. PubMed ID: 34976022
[TBL] [Abstract][Full Text] [Related]
6. m
Liao K; Hu J; Huang Y; Yu S; Yang Q; Sun F; Wu C; Cheng Y; Zhang W; Zhang X; Li H; Wang X
Front Oncol; 2022; 12():879405. PubMed ID: 35875124
[TBL] [Abstract][Full Text] [Related]
7. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.
Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R
Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630
[No Abstract] [Full Text] [Related]
8. Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases.
Wang Y; Wang J; Yan Z; Liu S; Xu W
BMC Pulm Med; 2023 Jun; 23(1):210. PubMed ID: 37328853
[TBL] [Abstract][Full Text] [Related]
9. Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers.
Tao Z; Zhao Y; Chen X
PeerJ; 2020; 8():e9589. PubMed ID: 32765970
[TBL] [Abstract][Full Text] [Related]
10. Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis.
Zhang J; Zhang Y; Wang Z; Zhao J; Li Z; Wang K; Tian L; Yao B; Wu Q; Wang T; Wang J
Front Genet; 2022; 13():1102422. PubMed ID: 36685949
[No Abstract] [Full Text] [Related]
11. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
[TBL] [Abstract][Full Text] [Related]
12. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm.
Li T; Wang T; Jing J; Sun L
J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic, Therapeutic, and Prognostic Value of the m
Gu Z; Du Y; Zhao X; Wang C
Front Cell Dev Biol; 2022; 10():822011. PubMed ID: 35223847
[TBL] [Abstract][Full Text] [Related]
15. METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.
Wang Y; Chen J; Gao WQ; Yang R
Cell Death Discov; 2022 Mar; 8(1):143. PubMed ID: 35354789
[TBL] [Abstract][Full Text] [Related]
16. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
Front Genet; 2021; 12():752025. PubMed ID: 35046996
[No Abstract] [Full Text] [Related]
17. Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.
Wang H; Yuan J; Dang X; Shi Z; Ban W; Ma D
Cell Biosci; 2021 Mar; 11(1):52. PubMed ID: 33706799
[TBL] [Abstract][Full Text] [Related]
18. METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.
Xu D; Han S; Yue X; Xu X; Huang T
Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37592151
[TBL] [Abstract][Full Text] [Related]
19. METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Cancer Manag Res; 2020; 12():13173-13184. PubMed ID: 33380825
[TBL] [Abstract][Full Text] [Related]
20. The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.
Yao Q; He L; Gao X; Tang N; Lin L; Yu X; Wang D
Front Oncol; 2021; 11():699749. PubMed ID: 34476213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
